Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022 -58.8% Revenue growth, 20223 Where the money goes Where each dollar of revenue went, fiscal 2022 Cost of revenue Interest
Cost of revenue 80¢ $1.1M Research and development 6¢ $85.0K Interest 14¢ $194.0K Income tax 0¢ $2.0K Out of $913.0K in revenue.3 The company lost money this year.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 7 8 3 $913.0K in 2022−84% since 2016 0 $2.0M $4.0M $6.0M 2016: $5.6M $5.6M 2016 2017: $4.9M $4.9M 2017 −12% 2018: $3.9M $3.9M 2018 −21% 2019: $3.7M $3.7M 2019 −6% 2020: $4.1M $4.1M 2020 +13% 2021: $2.2M $2.2M 2021 −47% 2022: $913.0K $913.0K 2022 −59% Gross profit4 5 6 7 8 3 -$103.0K in 2022-$1.0M 0 $1.0M $2.0M $3.0M 2016: $2.5M $2.5M 2016 2017: $2.0M $2.0M 2017 −20% 2018: $1.3M $1.3M 2018 −36% 2019: $1.2M $1.2M 2019 −8% 2020: $1.2M $1.2M 2020 +5% 2021: $548.0K $548.0K 2021 −56% 2022: -$103.0K -$103.0K 2022 Operating income4 5 6 7 8 3 -$1.2M in 2022+383% since 2016 -$1.5M -$1.0M -$500.0K 0 2016: -$257.0K -$257.0K 2016 2017: -$311.0K -$311.0K 2017 +21% 2018: -$762.0K -$762.0K 2018 +145% 2019: -$593.0K -$593.0K 2019 −22% 2020: -$621.0K -$621.0K 2020 +5% 2021: -$1.2M -$1.2M 2021 +90% 2022: -$1.2M -$1.2M 2022 +5% Net income4 5 6 7 8 3 -$1.4M in 2022+309% since 2016 -$1.5M -$1.0M -$500.0K 0 2016: -$345.0K -$345.0K 2016 2017: -$545.0K -$545.0K 2017 +58% 2018: -$1.0M -$1.0M 2018 +89% 2019: -$681.0K -$681.0K 2019 −34% 2020: -$796.0K -$796.0K 2020 +17% 2021: -$463.0K -$463.0K 2021 −42% 2022: -$1.4M -$1.4M 2022 +205%
No quarterly figures reported.
Fiscal year 2016 2017 2018 2019 2020 2021 2022 Revenue $5.6M4 $4.9M5 $3.9M6 $3.7M7 $4.1M8 $2.2M3 $913.0K3 Cost of revenue $3.1M4 $2.9M5 $2.6M6 $2.5M7 $2.9M8 $1.7M3 $1.1M3 Gross profit $2.5M4 $2.0M5 $1.3M6 $1.2M7 $1.2M8 $548.0K3 -$103.0K3 Research and development $184.0K4 $117.0K5 $93.0K6 $82.0K7 $90.0K8 $85.0K3 $85.0K3 Operating income -$257.0K4 -$311.0K5 -$762.0K6 -$593.0K7 -$621.0K8 -$1.2M3 -$1.2M3 Interest $284.0K4 $272.0K5 $284.0K6 $265.0K7 $175.0K8 $194.0K3 $194.0K3 Income tax $4.0K4 $05 $2.0K6 -$5.0K7 $2.0K8 $2.0K3 $2.0K3 Net income -$345.0K4 -$545.0K5 -$1.0M6 -$681.0K7 -$796.0K8 -$463.0K3 -$1.4M3 Earnings per share -$0.028 -$0.018
Total assets4 5 6 7 8 3 $1.3M in 2022−62% since 2016 0 $1.0M $2.0M $3.0M $4.0M 2016: $3.4M $3.4M 2016 2017: $2.9M $2.9M 2017 −14% 2018: $2.5M $2.5M 2018 −14% 2019: $2.1M $2.1M 2019 −16% 2020: $1.9M $1.9M 2020 −7% 2021: $1.9M $1.9M 2021 −2% 2022: $1.3M $1.3M 2022 −33% Total liabilities4 5 6 7 8 3 $3.6M in 2022+54% since 2016 0 $1.0M $2.0M $3.0M $4.0M 2016: $2.3M $2.3M 2016 2017: $2.3M $2.3M 2017 −3% 2018: $2.6M $2.6M 2018 +16% 2019: $2.9M $2.9M 2019 +9% 2020: $3.2M $3.2M 2020 +11% 2021: $2.8M $2.8M 2021 −11% 2022: $3.6M $3.6M 2022 +28% Shareholders’ equity5 6 7 3 -$2.3M in 2022-$3.0M -$2.0M -$1.0M 0 $1.0M $2.0M 2016: $1.0M $1.0M 2016 2017: $623.0K $623.0K 2017 −39% 2018: -$146.0K -$146.0K 2018 2019: -$790.0K -$790.0K 2019 +441% 2020: -$1.3M -$1.3M 2020 +59% 2021: -$944.0K -$944.0K 2021 −25% 2022: -$2.3M -$2.3M 2022 +148% Cash5 6 7 8 3 $34.0K in 2022−78% since 2016 0 $50.0K $100.0K $150.0K $200.0K 2016: $156.0K $156.0K 2016 2017: $36.0K $36.0K 2017 −77% 2018: $113.0K $113.0K 2018 +214% 2019: $4.0K $4.0K 2019 −96% 2020: $98.0K $98.0K 2020 +2350% 2021: $115.0K $115.0K 2021 +17% 2022: $34.0K $34.0K 2022 −70% Long-term debt4 5 6 7 3 $2.2M in 2022+196% since 2016 0 $1.0M $2.0M $3.0M 2016: $753.0K $753.0K 2016 2017: $791.0K $791.0K 2017 +5% 2018: $796.0K $796.0K 2018 +1% 2019: $1.1M $1.1M 2019 +41% 2020: $1.1M $1.1M 2020 −0% 2021: $1.5M $1.5M 2021 +38% 2022: $2.2M $2.2M 2022 +45%
Total assets9 $659.0K in Q1 FY2023−48% since Q1 FY2022 0 $500.0K $1.0M $1.5M Q1 FY2022: $1.3M $1.3M Q1 FY2022 Q1 FY2023: $659.0K $659.0K Q1 FY2023 −48% Total liabilities9 $1.1M in Q1 FY2023−69% since Q1 FY2022 0 $1.0M $2.0M $3.0M $4.0M Q1 FY2022: $3.6M $3.6M Q1 FY2022 Q1 FY2023: $1.1M $1.1M Q1 FY2023 −69% Shareholders’ equity9 -$458.0K in Q1 FY2023−80% since Q1 FY2022 -$3.0M -$2.0M -$1.0M 0 Q1 FY2022: -$2.3M -$2.3M Q1 FY2022 Q1 FY2023: -$458.0K -$458.0K Q1 FY2023 −80% Cash9 $68.0K in Q1 FY2023+100% since Q1 FY2022 0 $20.0K $40.0K $60.0K $80.0K Q1 FY2022: $34.0K $34.0K Q1 FY2022 Q1 FY2023: $68.0K $68.0K Q1 FY2023 +100% Long-term debt9 $175.0K in Q1 FY2023−92% since Q1 FY2022 0 $1.0M $2.0M $3.0M Q1 FY2022: $2.2M $2.2M Q1 FY2022 Q1 FY2023: $175.0K $175.0K Q1 FY2023 −92%
Fiscal year 2016 2017 2018 2019 2020 2021 2022 Cash $156.0K5 $36.0K6 $113.0K7 $4.0K8 $98.0K8 $115.0K3 $34.0K3 Current assets $2.4M4 $2.0M5 $1.6M6 $1.2M7 $1.2M8 $1.3M3 $769.0K3 Total assets $3.4M4 $2.9M5 $2.5M6 $2.1M7 $1.9M8 $1.9M3 $1.3M3 Current liabilities $1.6M4 $1.5M5 $1.8M6 $1.7M7 $2.0M8 $2.8M3 $3.6M3 Long-term debt $753.0K4 $791.0K5 $796.0K6 $1.1M7 $1.1M7 $1.5M3 $2.2M3 Total liabilities $2.3M4 $2.3M5 $2.6M6 $2.9M7 $3.2M8 $2.8M3 $3.6M3 Shareholders’ equity $1.0M5 $623.0K6 -$146.0K7 -$790.0K7 -$1.3M3 -$944.0K3 -$2.3M3 Shares outstanding 28.8M shares4 29.8M shares5 32.3M shares6 32.7M shares7 37.7M shares8 47.6M shares3 48.1M shares3
Cash from operations7 8 3 -$768.0K in 2022-$1.0M -$750.0K -$500.0K -$250.0K 0 $250.0K 2019: $58.0K $58.0K 2019 2020: -$483.0K -$483.0K 2020 2021: -$673.0K -$673.0K 2021 +39% 2022: -$768.0K -$768.0K 2022 +14% Capital spending4 5 7 8 $0 in 20210 $20.0K $40.0K $60.0K 2016: $0 $0 2016 2017: $44.0K $44.0K 2017 2018: $0 $0 2018 2019: $0 $0 2019 2020: $4.0K $4.0K 2020 2021: $0 $0 2021 Free cash flow7 8 3 -$673.0K in 2021-$800.0K -$600.0K -$400.0K -$200.0K 0 $200.0K 2019: $58.0K $58.0K 2019 2020: -$487.0K -$487.0K 2020 2021: -$673.0K -$673.0K 2021 +38%
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2016 2017 2018 2019 2020 2021 2022 Cash from operations $58.0K7 -$483.0K8 -$673.0K3 -$768.0K3 Capital spending $04 $44.0K5 $05 $07 $4.0K8 $08 Free cash flow $58.0K -$487.0K -$673.0K
Compare AMERICAN BIO MEDICA CORP with another company
Recent filings
Jun 12, 2023 10-Q Mar 21, 2023 10-K Mar 1, 2023 8-K Feb 17, 2023 8-K Jan 11, 2023 DEF 14A Dec 21, 2022 8-K Nov 16, 2022 10-Q Aug 15, 2022 10-Q Jun 29, 2022 8-K May 16, 2022 10-Q Apr 28, 2022 DEF 14A SCHEDULE 14AApr 15, 2022 10-K Mar 14, 2022 8-K Dec 22, 2021 8-K CURRENT REPORTNov 29, 2021 4 OWNERSHIP DOCUMENT
Every filing from the last three years, summarized . The full record is on SEC EDGAR.1